Join to View Full Profile
2050 Kenny RdTower 10th FloorColumbus, OH 43221
Phone+1 614-293-8629
Fax+1 614-293-3112
Dr. Konda is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Hematology and Medical Oncology, 2012 - 2015
University of Miami Hospital and Clinics/Holy Cross HospitalResidency, Internal Medicine, 2009 - 2012
Osmania Medical College NTR UHSClass of 2007
Certifications & Licensure
OH State Medical License 2015 - 2026
FL State Medical License 2009 - 2013
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Testing the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid Cancer Start of enrollment: 2020 Feb 10
Publications & Presentations
PubMed
- Response to Letter to the Editor from Zhang et al.: Cabozantinib plus ipilimumab/nivolumab in patients with previously treated advanced differentiated thyroid cancer.Bhavana Konda, Eric J Sherman, Erminia Massarelli, Jorge Nieva, Jameel Muzaffar
The Journal of Clinical Endocrinology and Metabolism. 2025-04-04 - 2 citationsClinical Activity of Selpercatinib in RET-mutant Pheochromocytoma.Barbara Deschler-Baier, Bhavana Konda, Erminia Massarelli, Mimi I Hu, Lori J Wirth
The Journal of Clinical Endocrinology and Metabolism. 2025-02-18 - 1 citationsCabozantinib Plus Ipilimumab/Nivolumab in Patients With Previously Treated Advanced Differentiated Thyroid Cancer.Bhavana Konda, Eric J Sherman, Erminia Massarelli, Jorge Nieva, Jameel Muzaffar
The Journal of Clinical Endocrinology and Metabolism. 2025-02-18
Journal Articles
- Prognostic Impact of Serum Pancreastatin Following Chemoembolization for Neuroendocrine TumorsNeil Saunders, David Strosberg, Jill Onesti, Carl R Schmidt, Manisha Shah, Mary Dillhoff, Lawrence A Shirley, Bhavana Konda, Annals of Surgical Oncology
Press Mentions
Preview of the 93rd American Thyroid Association Annual MeetingJuly 1st, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
